Author:
Orallo Dalila E.,Fuentes Giselle M.,Benavidez María G.,Suárez Patricia A.,Nutter Diego,Fangio María F.,Ramirez Cristina L.
Funder
Universidad Nacional de Mar del Plata
Reference58 articles.
1. The use of compounds derived from Cannabis sativa in the treatment of epilepsy, painful conditions, and neuropsychiatric and neurodegenerative disorders;Stasiłowicz-Krzemień;Int. J. Mol. Sci.,2024
2. Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process;Bhaskar;J. Cannabis Res,2022
3. Clinical and cognitive improvement following full-spectrum, high-cannabidiol treatment for anxiety: open-label data from a two-stage, phase 2 clinical trial;Dahlgren;Commun. Med.,2022
4. Cannabis sativa L.: a review on traditional uses, botany, phytochemistry, and pharmacological aspects;Chaachouaya;Tradit. Integr. Med.,2023
5. Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial;Grimison;Ann. Oncol.,2020